MUSCAT – Dr. Najeeb bin Zahran Al Rawahi, Director of the National Heart Center and Head of the Medical Team, explained to Oman News Agency that the operation was performed on a patient who suffers from frequent fainting and cardiac arrest for periods of up to 5 seconds, which could lead to death. He said that the operation was crowned with success and the patient underwent observation for one day after the operation to monitor her health condition; she will be followed up periodically, at intervals between 4 and 6 months.

He stated that the implantation of the Aveir wireless pacemaker in the body was done through a catheter, and this operation was nonsurgical, but rather required a small incision through the venous thigh no more than two centimeters without the need for general anesthesia; it took only half an hour. He stressed that this achievement comes less than a month after the FDA approved the use of the device as a dual chamber leadless pacemaker system. He explained that catheterization is a less invasive medical procedure than surgery, and does not require a long recovery period – the recovery period is shorter compared to surgeries that require a longer intensive care period in the hospital. He indicated that the Aveir wireless pacemaker works by sending electrical signals to regulate the heartbeat and that this technology is a breakthrough in the treatment of heart problems, as the device can regulate heartbeats and improve heart function in general.
The device has a long battery life of up to 20 years, which means that the patient will not need to replace the battery frequently. And when the battery life runs out, the device can be easily removed through a catheter and replaced with a new one. He stressed that the wireless pacemaker from Abbott is an innovative and effective technology for treating heart problems and provides a longer battery life with the ability to be easily removed when needed. He added that the National Heart Center at the Royal Hospital is one of the first centers in the region to provide this technology to patients.
Read More
- TAS Conclave 2025: Investment leaders highlight Oman’s emerging position as a regional investment hub
- “Dialogue can truly drive progress”: TAS CEO Nishad Padiyarath reflects on five years of TAS Conclave
- TAS Conclave 2025 concludes successfully, spotlighting Oman’s path toward Vision 2040
- 5th edition of TAS Conclave honours top five TAS Icons
- His Excellency Qais Al Yousef presents prestigious Business Awards at TAS Conclave 2025





